CLINICAL_TRIALS trial_result · 2016-03-11

Clinical Trial Update: Ticagrelor in Severe Community Acquired Pneumonia [Phase 2]

A Phase 2 trial evaluating ticagrelor for severe community-acquired pneumonia was terminated, with results posted in March 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Gordon Bernard | Conditions: Community Acquired Pneumonia, Severe | Phase 2 | Status: TERMINATED | Results posted: 2016-03-11